Home > Research > Publications & Outputs > Production and characterization of stable ampho...
View graph of relations

Production and characterization of stable amphotericin-resistant amastigotes and promastigotes of Leishmania mexicana

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published

Standard

Production and characterization of stable amphotericin-resistant amastigotes and promastigotes of Leishmania mexicana. / Al-Mohammed, Hamdan I; Chance, Michael L; Bates, Paul A.
In: Antimicrobial Agents and Chemotherapy, Vol. 49, No. 8, 2005, p. 3274-3280.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

APA

Vancouver

Al-Mohammed HI, Chance ML, Bates PA. Production and characterization of stable amphotericin-resistant amastigotes and promastigotes of Leishmania mexicana. Antimicrobial Agents and Chemotherapy. 2005;49(8):3274-3280. doi: 10.1128/AAC.49.8.3274-3280.2005

Author

Al-Mohammed, Hamdan I ; Chance, Michael L ; Bates, Paul A. / Production and characterization of stable amphotericin-resistant amastigotes and promastigotes of Leishmania mexicana. In: Antimicrobial Agents and Chemotherapy. 2005 ; Vol. 49, No. 8. pp. 3274-3280.

Bibtex

@article{3f07697cb5cb4105b953d438cded7f4d,
title = "Production and characterization of stable amphotericin-resistant amastigotes and promastigotes of Leishmania mexicana",
abstract = "The sensitivities of Leishmania mexicana amastigote and promastigote forms to amphotericin B were investigated in vitro and found to be strongly influenced by the culture media used. When differences in culture media were minimized, there was no significant difference in the 50% inhibitory concentration values between the two life cycle stages. Stable amphotericin B-resistant amastigote and promastigote lines were produced by the application of increasing drug pressure to long-term cultures. Lines capable of growth in concentrations of amphotericin B lethal to normal parasites were produced. Compared to normal parasites, these amphotericin-resistant lines showed marked differences in membrane sterol compositions, with very high levels of 4,14,dimethyl-cholesta-8,24-dienol and other methyl sterols. They also showed a consistent morphological feature, the presence of multilamellar membrane-like material in the flagellar pocket, revealed by transmission electron microscopy. Amphotericin-resistant parasites were capable of infecting BALB/c mice, but the resulting lesion growth was slower than that after infection with normal parasites. However, unlike normal parasites, the amphotericin-resistant parasites were unaffected by experimental chemotherapy with amphotericin B. These results show that amphotericin B resistance could arise as a result of increased clinical use of amphotericin B therapy.",
author = "Al-Mohammed, {Hamdan I} and Chance, {Michael L} and Bates, {Paul A}",
year = "2005",
doi = "10.1128/AAC.49.8.3274-3280.2005",
language = "English",
volume = "49",
pages = "3274--3280",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "8",

}

RIS

TY - JOUR

T1 - Production and characterization of stable amphotericin-resistant amastigotes and promastigotes of Leishmania mexicana

AU - Al-Mohammed, Hamdan I

AU - Chance, Michael L

AU - Bates, Paul A

PY - 2005

Y1 - 2005

N2 - The sensitivities of Leishmania mexicana amastigote and promastigote forms to amphotericin B were investigated in vitro and found to be strongly influenced by the culture media used. When differences in culture media were minimized, there was no significant difference in the 50% inhibitory concentration values between the two life cycle stages. Stable amphotericin B-resistant amastigote and promastigote lines were produced by the application of increasing drug pressure to long-term cultures. Lines capable of growth in concentrations of amphotericin B lethal to normal parasites were produced. Compared to normal parasites, these amphotericin-resistant lines showed marked differences in membrane sterol compositions, with very high levels of 4,14,dimethyl-cholesta-8,24-dienol and other methyl sterols. They also showed a consistent morphological feature, the presence of multilamellar membrane-like material in the flagellar pocket, revealed by transmission electron microscopy. Amphotericin-resistant parasites were capable of infecting BALB/c mice, but the resulting lesion growth was slower than that after infection with normal parasites. However, unlike normal parasites, the amphotericin-resistant parasites were unaffected by experimental chemotherapy with amphotericin B. These results show that amphotericin B resistance could arise as a result of increased clinical use of amphotericin B therapy.

AB - The sensitivities of Leishmania mexicana amastigote and promastigote forms to amphotericin B were investigated in vitro and found to be strongly influenced by the culture media used. When differences in culture media were minimized, there was no significant difference in the 50% inhibitory concentration values between the two life cycle stages. Stable amphotericin B-resistant amastigote and promastigote lines were produced by the application of increasing drug pressure to long-term cultures. Lines capable of growth in concentrations of amphotericin B lethal to normal parasites were produced. Compared to normal parasites, these amphotericin-resistant lines showed marked differences in membrane sterol compositions, with very high levels of 4,14,dimethyl-cholesta-8,24-dienol and other methyl sterols. They also showed a consistent morphological feature, the presence of multilamellar membrane-like material in the flagellar pocket, revealed by transmission electron microscopy. Amphotericin-resistant parasites were capable of infecting BALB/c mice, but the resulting lesion growth was slower than that after infection with normal parasites. However, unlike normal parasites, the amphotericin-resistant parasites were unaffected by experimental chemotherapy with amphotericin B. These results show that amphotericin B resistance could arise as a result of increased clinical use of amphotericin B therapy.

U2 - 10.1128/AAC.49.8.3274-3280.2005

DO - 10.1128/AAC.49.8.3274-3280.2005

M3 - Journal article

C2 - 16048936

VL - 49

SP - 3274

EP - 3280

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 8

ER -